$2.90
0.26[9.85%]
At close: Apr 24
$2.90
0[0.00%]
After Hours: 7:53AM EDT
LAVA Therapeutics
(NASDAQ:LVTX)LAVA Therapeutics Stock (NASDAQ:LVTX), Analyst Ratings, Price Targets, Predictions
LAVA Therapeutics NV has a consensus price target of $12.25, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and JMP Securities on March 21, 2024, November 17, 2023, and August 23, 2023. With an average price target of $6 between HC Wainwright & Co., HC Wainwright & Co., and JMP Securities, there's an implied 119.78% upside for LAVA Therapeutics NV from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
JMP Securities
HC Wainwright & Co.
SVB Leerink
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for LAVA Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/21/2024 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | HC Wainwright & Co. | Arthur He | → $6 | Reiterates | Buy → Buy | Get Alert |
| 11/17/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | HC Wainwright & Co. | Arthur He | → $6 | Reiterates | Buy → Buy | Get Alert |
| 08/23/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | JMP Securities | Reni Benjamin | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/23/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | HC Wainwright & Co. | Arthur He | $9 → $6 | Maintains | Buy | Get Alert |
| 06/15/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | JMP Securities | Reni Benjamin | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 06/12/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 229.67% | HC Wainwright & Co. | Arthur He | → $9 | Reiterates | Buy → Buy | Get Alert |
| 06/09/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | JMP Securities | Reni Benjamin | → $6 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 04/13/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 229.67% | HC Wainwright & Co. | Arthur He | → $9 | Reiterates | → Buy | Get Alert |
| 02/17/2023 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 229.67% | HC Wainwright & Co. | Swayampakula Ramakanth | → $9 | Reiterates | → Buy | Get Alert |
| 10/25/2022 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 229.67% | HC Wainwright & Co. | Arthur He | → $9 | Initiates | → Buy | Get Alert |
| 09/27/2022 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 925.64% | SVB Leerink | Daina Graybosch | $25 → $28 | Maintains | Outperform | Get Alert |
| 09/15/2022 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 119.78% | JMP Securities | Reni Benjamin | → $6 | Initiates | → Market Outperform | Get Alert |
| 05/18/2022 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 815.75% | SVB Leerink | Daina Graybosch | $23 → $25 | Maintains | Outperform | Get Alert |
| 11/16/2021 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 632.6% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
| 08/17/2021 | LVTX | Buy Now | LAVA Therapeutics | $2.73 | 779.12% | SVB Leerink | Daina Graybosch | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for LAVA Therapeutics (LVTX)?
The latest price target for LAVA Therapeutics (NASDAQ: LVTX) was reported by HC Wainwright & Co. on March 21, 2024. The analyst firm set a price target for $6.00 expecting LVTX to rise to within 12 months (a possible 106.90% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for LAVA Therapeutics (LVTX)?
The latest analyst rating for LAVA Therapeutics (NASDAQ: LVTX) was provided by HC Wainwright & Co., and LAVA Therapeutics reiterated their buy rating.
When was the last upgrade for LAVA Therapeutics (LVTX)?
There is no last upgrade for LAVA Therapeutics.
When was the last downgrade for LAVA Therapeutics (LVTX)?
There is no last downgrade for LAVA Therapeutics.
When is the next analyst rating going to be posted or updated for LAVA Therapeutics (LVTX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LAVA Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LAVA Therapeutics was filed on March 21, 2024 so you should expect the next rating to be made available sometime around March 21, 2025.
Is the Analyst Rating LAVA Therapeutics (LVTX) correct?
While ratings are subjective and will change, the latest LAVA Therapeutics (LVTX) rating was a reiterated with a price target of $0.00 to $6.00. The current price LAVA Therapeutics (LVTX) is trading at is $2.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.